Restructuring (Notes)
 12 Months Ended
Mar. 31, 2020
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block]
2. RESTRUCTURING
Fiscal 2019 Restructuring Plan. During the third quarter of fiscal 2019, we adopted and announced a targeted restructuring plan (the "Fiscal 2019 Restructuring Plan"), which included the closure of two manufacturing facilities, one in Brazil and one in England, as well as other actions including the rationalization of certain products. Fewer than 200 positions were eliminated. The Company has relocated the production of certain impacted products to other existing manufacturing operations during fiscal 2020. These restructuring actions were designed to enhance profitability and improve efficiency.
Since inception of the Fiscal 2019 Restructuring Plan we have incurred pre-tax expenses totaling $43,851 related to these restructuring actions, of which $31,660 was recorded as restructuring expenses and $12,191 was recorded in cost of revenues, with a total of $31,162, $2,518, $668, and $7,798 related to the Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies segments, respectively. Corporate related restructuring charges were $1,705. Additional restructuring expenses related to this plan are not expected to be material to our results of operations.
The following table summarizes our total pre-tax restructuring expenses for fiscal 2020 and 2019:
Fiscal 2019 Restructuring Plan
Year Ended March 31, 2020
Year Ended March 31, 2019
Severance and other compensation related costs
$
1,554

$
5,651

         Accelerated depreciation and amortization
—

16,194

        (Gain) on disposal of asset
(1,164
)
—

         Asset impairment
—

4,312

Lease termination costs and other
283

4,830

Product rationalization (1)
2,470

9,721

Total restructuring expenses
$
3,143

$
40,708

(1) Recorded in cost of revenues on the Consolidated Statements of Income.

Liabilities related to restructuring activities are recorded as current liabilities on the accompanying Consolidated Balance Sheets within “Accrued payroll and other related liabilities” and “Accrued expenses and other.” The following tables summarize our restructuring liability balances:
Fiscal 2019 Restructuring Plan
 
March 31,
2019
 
Provisions
 
Payments /Impairments (1)
 
March 31,
2020
Severance and termination benefits
 
$
4,102

 
$
1,554

 
$
(4,659
)
 
$
997

Lease termination obligations and other
 
2,029

 
283

 
(2,292
)
 
20

Total
 
$
6,131

 
$
1,837

 
$
(6,951
)
 
$
1,017

(1) Certain amounts reported include the impact of foreign currency movements relative to the U.S. dollar.
Fiscal 2019 Restructuring Plan
 
March 31,
2018
 
Provisions
 
Payments /Impairments (1)
 
March 31,
2019
Severance and termination benefits
 
$
—

 
$
5,651

 
$
(1,549
)
 
$
4,102

Lease termination obligations and other
 
—

 
4,830

 
(2,801
)
 
2,029

Total
 
$
—

—

$
10,481

—

$
(4,350
)
—

$
6,131

(1) Certain amounts reported include the impact of foreign currency movements relative to the U.S. dollar.